OC
Opal Capital Portfolio holdings
AUM
$400M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$400M
AUM Growth
–
Holding
187
Top Buys
| 1 | +$13.6M | |
| 2 | +$11.5M | |
| 3 | +$11.3M | |
| 4 |
Verizon
VZ
|
+$11.1M |
| 5 |
Novo Nordisk
NVO
|
+$10.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 14.78% |
| 2 | Consumer Staples | 13.28% |
| 3 | Healthcare | 12.01% |
| 4 | Technology | 11.69% |
| 5 | Energy | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ameriprise Financial
AMP
$43.7B
| $204K | 0.05% |
+386
|
|
||
177
iShares S&P 100 ETF
OEF
$29B
| $204K | 0.05% |
+1,328
|
|
||
178
Tyson Foods
TSN
$22B
| $203K | 0.05% |
+3,101
|
|
||
179
Schwab US Dividend Equity ETF
SCHD
$84.6B
| $203K | 0.05% |
+6,461
|
|
||
180
Coca-Cola
KO
$346B
| $203K | 0.05% |
+2,597
|
|
||
181
Nurix Therapeutics
NRIX
$1.62B
| $202K | 0.05% |
+12,078
|
|
||
182
Zentalis Pharmaceuticals
ZNTL
$160M
| $173K | 0.04% |
+72,251
|
|
||
183
Ford
F
$57.6B
| $166K | 0.04% |
+12,410
|
|
||
184
Aura Biosciences
AURA
$382M
| $127K | 0.03% |
+22,034
|
|
||
185
908 Devices
MASS
$247M
| $121K | 0.03% |
+17,581
|
|
||
186
Relay Therapeutics
RLAY
$1.6B
| $98.6K | 0.02% |
+11,401
|
|
||
187
Pulmonx
LUNG
$67.2M
| $20K | 0.01% |
+12,984
|
|